Biblio

Export 476 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
Journal Article
S. L. C. Geijselaers, Aalten, P., Ramakers, I. H. G. B., De Deyn, P. Paul, Heijboer, A. C., Koek, H. L., OldeRikkert, M. G. M., Papma, J. M., Reesink, F. E., Smits, L. L., Stehouwer, C. D. A., Teunissen, C. E., Verhey, F. R. J., van der Flier, W. M., and Biessels, G. Jan, Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 309-320, 2018.
S. J. Teipel, Dyrba, M., Ballarini, T., Brosseron, F., Bruno, D., Buerger, K., Cosma, N. - C., Dechent, P., Dobisch, L., Düzel, E., Ewers, M., Fliessbach, K., Haynes, J. D., Janowitz, D., Kilimann, I., Laske, C., Maier, F., Metzger, C. D., Munk, M. H., Peters, O., Pomara, N., Preis, L., Priller, J., Rámirez, A., Roy, N., Scheffler, K., Schneider, A., Schott, B. H., Spottke, A., Spruth, E. J., Wagner, M., Wiltfang, J., Jessen, F., and Heneka, M. T., Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum., J Alzheimers Dis, vol. 85, no. 3, pp. 1267-1282, 2022.
L. Wang, Davis, P. B., Volkow, N. D., Berger, N. A., Kaelber, D. C., and Xu, R., Association of COVID-19 with New-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 89, no. 2, pp. 411-414, 2022.
C. - C. Tan, Wan, Y., Tan, M. - S., Zhang, W., Wang, Z. - X., Sun, F. - R., Miao, D., Tan, L., and Yu, J. - T., Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer's Disease in a Northern Han Chinese Population., J Alzheimers Dis, vol. 52, no. 1, pp. 43-50, 2016.
D. Bensamoun, Guignard, R., Furst, A. J., Derreumaux, A., Manera, V., Darcourt, J., Benoit, M., Robert, P. H., and David, R., Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People., J Alzheimers Dis, vol. 49, no. 2, pp. 387-98, 2016.
M. E. Flanagan, Larson, E. B., Walker, R. L., C Keene, D., Postupna, N., Cholerton, B., Sonnen, J. A., Dublin, S., Crane, P. K., and Montine, T. J., Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex., J Alzheimers Dis, vol. 61, no. 2, pp. 653-662, 2018.
W. M. A. D. Bino Fernando, Rainey-Smith, S. R., Gardener, S. L., Villemagne, V. L., Burnham, S. C., S Macaulay, L., Brown, B. M., Gupta, V. Bala, Sohrabi, H. R., Weinborn, M., Taddei, K., Laws, S. M., Goozee, K., Ames, D., Fowler, C., Maruff, P., Masters, C. L., Salvado, O., Rowe, C. C., and Martins, R. N., Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β., J Alzheimers Dis, vol. 61, no. 4, pp. 1589-1598, 2018.
T. Daly, Mastroleo, I., and Migliaccio, R., Avoiding Over-Reliance on Multi-Domain Interventions for Dementia Prevention., J Alzheimers Dis, vol. 90, no. 3, pp. 989-992, 2022.
A. Tsugawa, Sakurai, S., Inagawa, Y., Hirose, D., Kaneko, Y., Ogawa, Y., Serisawa, S., Takenoshita, N., Sakurai, H., Kanetaka, H., Hirao, K., and Shimizu, S., Awareness of the COVID-19 Outbreak and Resultant Depressive Tendencies in Patients with Severe Alzheimer's Disease., J Alzheimers Dis, vol. 77, no. 2, pp. 539-541, 2020.
M. A. Parra, Barriers to Effective Memory Assessments for Alzheimer's Disease., J Alzheimers Dis, vol. 90, no. 3, pp. 981-988, 2022.
E. Schwertner, Pereira, J. B., Xu, H., Secnik, J., Winblad, B., Eriksdotter, M., Nägga, K., and Religa, D., Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals., J Alzheimers Dis, vol. 87, no. 3, pp. 1307-1318, 2022.
M. Ibarria, Alegret, M., Valero, S., Morera, A., Guitart, M., Cañabate, P., Moreno, M., Lara, S., Diego, S., Hernández, J., Tantinyá, N., Vera, M., Hernandez, I., Becker, J. T., Ruiz, A., Boada, M., and Tárraga, L., Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
K. Le Guennec, Tubeuf, H., Hannequin, D., Wallon, D., Quenez, O., Rousseau, S., Richard, A. - C., Deleuze, J. - F., Boland, A., Frebourg, T., Gaildrat, P., Campion, D., Martins, A., and Nicolas, G., Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer's Disease Patient., J Alzheimers Dis, vol. 62, no. 2, pp. 821-831, 2018.
A. Mulak, Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease., J Alzheimers Dis, vol. 84, no. 2, pp. 461-477, 2021.
T. Dziedzic, Pera, J., Klimkowicz-Mrowiec, A., Mroczko, B., and Slowik, A., Biochemical and Radiological Markers of Alzheimer's Disease Progression., J Alzheimers Dis, vol. 50, no. 3, pp. 623-44, 2016.
D. R. Galasko, Grill, J. D., Lingler, J. H., and Heidebrink, J. L., A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?, J Alzheimers Dis, vol. 90, no. 3, pp. 963-966, 2022.
T. K. Karikari, Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance., J Alzheimers Dis, vol. 90, no. 3, pp. 967-974, 2022.
I. Koychev, Jansen, K., Dette, A., Shi, L., and Holling, H., Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis., J Alzheimers Dis, vol. 79, no. 1, pp. 177-195, 2021.
A. Malishkevich, Marshall, G. A., Schultz, A. P., Sperling, R. A., Aharon-Peretz, J., and Gozes, I., Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers., J Alzheimers Dis, vol. 50, no. 1, pp. 249-60, 2016.
F. Guillot, Kemppainen, S., Lavasseur, G., Miettinen, P. O., Laroche, S., Tanila, H., and Davis, S., Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1157-73, 2016.
H. - F. Wang, Wan, Y., Hao, X. - K., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Tan, L., Zhang, D. - Q., Tan, L., and Yu, J. - T., Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration., J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.
I. A. Clark and Vissel, B., Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches., J Alzheimers Dis, vol. 79, no. 3, pp. 931-948, 2021.
R. Benca, W Herring, J., Khandker, R., and Qureshi, Z. P., Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review., J Alzheimers Dis, vol. 86, no. 1, pp. 83-109, 2022.
H. Khodadadi, Salles, É. Lopes, Jarrahi, A., Costigliola, V., Khan, M. B., Yu, J. C., Morgan, J. C., Hess, D. C., Vaibhav, K., Dhandapani, K. M., and Baban, B., Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease., J Alzheimers Dis, vol. 80, no. 3, pp. 973-977, 2021.
E. Aso, Andrés-Benito, P., Carmona, M., Maldonado, R., and Ferrer, I., Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine., J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.

Pages